|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 37.37 USD | +6.65% |
|
+7.48% | -5.54% |
| 24/07 | AtriCure, Inc., Q2 2026 Earnings Call, Jul 23, 2026 | |
| 24/07 | AtriCure Q2 Swings to Adjusted Earnings, Revenue Rises | MT |
Company Valuation: AtriCure, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 3,194 | 2,064 | 1,692 | 1,490 | 1,967 | 1,892 | - | - |
| Change | - | -35.37% | -18.05% | -11.92% | 32.01% | -3.78% | - | - |
| Enterprise Value (EV) 1 | 3,210 | 2,063 | 1,623 | 1,441 | 1,873 | 1,737 | 1,660 | 1,545 |
| Change | - | -35.73% | -21.32% | -11.21% | 29.97% | -7.22% | -4.45% | -6.91% |
| P/E | 63.8x | -43.5x | -54.1x | -32.2x | -165x | 354x | 89.4x | 53.8x |
| PBR | 6.61x | 4.52x | 3.55x | 3.24x | 4x | 3.29x | 2.94x | 2.58x |
| PEG | - | 0x | 1.5x | -0.7x | 2.2x | -2x | 0x | 0.8x |
| Capitalization / Revenue | 11.6x | 6.25x | 4.24x | 3.2x | 3.68x | 3.12x | 2.79x | 2.48x |
| EV / Revenue | 11.7x | 6.24x | 4.06x | 3.1x | 3.5x | 2.87x | 2.44x | 2.02x |
| EV / EBITDA | -366x | -943x | 83.5x | 46.3x | 30.3x | 19.9x | 16.3x | 12.6x |
| EV / EBIT | -67.9x | -48.3x | -60.8x | -36x | -198x | 158x | 65.2x | 36.6x |
| EV / FCF | -136x | -52.9x | -216x | 1,934x | 38.8x | 32.8x | 41.5x | - |
| FCF Yield | -0.73% | -1.89% | -0.46% | 0.05% | 2.58% | 3.05% | 2.41% | - |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | 1.09 | -1.02 | -0.66 | -0.95 | -0.24 | 0.1056 | 0.418 | 0.6942 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 274.3 | 330.4 | 399.2 | 465.3 | 534.5 | 606.1 | 679.2 | 764.5 |
| EBITDA 1 | -8.776 | -2.188 | 19.45 | 31.12 | 61.77 | 87.33 | 101.6 | 122.8 |
| EBIT 1 | -47.3 | -42.67 | -26.68 | -40.01 | -9.447 | 10.99 | 25.45 | 42.25 |
| Net income 1 | 50.2 | -46.47 | -34.85 | -44.7 | -11.45 | 6.321 | 20.68 | 35.01 |
| Net Debt 1 | 16.09 | -1.265 | -68.63 | -49 | -94.05 | -155 | -232.3 | -347 |
| Reference price 2 | 69.53 | 44.38 | 35.69 | 30.56 | 39.56 | 37.37 | 37.37 | 37.37 |
| Nbr of stocks (in thousands) | 45,932 | 46,508 | 47,395 | 48,753 | 49,717 | 50,641 | - | - |
| Announcement Date | 15/2/22 | 21/2/23 | 15/2/24 | 12/2/25 | 17/2/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 331.88x | 2.67x | 18.54x | - | 1.77B | |
| 29.22x | 4.03x | 15.68x | 2.51% | 180B | |
| 18.88x | 3.31x | 11.63x | 3.57% | 107B | |
| 17.24x | 0.19x | 12.17x | 0.77% | 60.29B | |
| 30.98x | 7.52x | 19.65x | 1.29% | 50.19B | |
| 38.96x | 3.1x | 10.58x | 2.46% | 43.08B | |
| 37.15x | 1.36x | 11.97x | 0.26% | 32.77B | |
| 29.08x | 5.2x | 16.59x | -.--% | 27.61B | |
| 38.27x | 6.7x | 24x | 0.28% | 23.1B | |
| 23.57x | 3.45x | 12.39x | 1.23% | 20.86B | |
| Average | 59.52x | 3.75x | 15.32x | 1.38% | 54.57B | |
| Weighted average by Cap. | 28.43x | 3.70x | 14.52x | 2% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- ATRC Stock
- Valuation AtriCure, Inc.
Select your edition
All financial news and data tailored to specific country editions
